Dr. Maria Francis Schnitzer, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1301 Bertha Howe Ave, Ste. 1, Mesquite, NV 89027 Phone: 702-346-0800 Fax: 702-346-0801 |
Dr. Robert R Foster, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1299 Bertha Howe Ave, Mesquite, NV 89027 Phone: 702-345-4270 |
Dr. Donald C Hansen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1299 Bertha Howe Ave, Mesquite, NV 89027 Phone: 702-345-4270 |
Ediriel Hernandez-salas, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1299 Bertha Howe Ave, Mesquite, NV 89027 Phone: 702-345-4303 |
News Archive
In an article featured on the cover of the March issue of Nature Nanotechnology, Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston, presented a proof-of-concept study on a new multistage delivery system (MDS) for imaging and therapeutic applications. This discovery could go a long way toward making injectable drugs more effective.
Opponents of the health law argue that the legislative language never says subsidies can be used to defray premium costs for low- and moderate-income people who live in states that did not set up their own online marketplaces and are served instead by the federal exchange. Also, in news about how the law is being implemented, a look at who is exempted from the mandate to get insurance.
Hot flashes. Night sweats. These are the most common - or at least the most commonly talked about - symptoms of menopause. But one reality of The Change for many women is less discussed yet no less important: problems with vaginal health and sexual function.
On this week's episode of "America Dissected," host Dr. Abdul El-Sayed spoke with Dr. Paloma Marin-Nevarez, an emergency medicine resident at UCSF Fresno, and KHN senior correspondent Jenny Gold about the challenges Marin-Nevarez faced as a new doctor learning the ropes during a devastating pandemic.
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, today announced the initiation of its Phase 2 trial evaluating voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES).
› Verified 1 days ago